fbpx
Skip to content

FDA Announces Shortage of Adderall

Slack imgs. Com adhd online

This a public announcement that the FDA made about Adderall.

On October 12, 2022, FDA posted a shortage of the immediate-release formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall or Adderall IR, on our drug shortage website. FDA is in frequent communication with all manufacturers of amphetamine mixed salts, and one of those companies, Teva, is experiencing ongoing intermittent manufacturing delays. Other manufacturers continue to produce amphetamine mixed salts, but there is not sufficient supply to continue to meet U.S. market demand through those producers.

Amphetamine mixed salts, including Adderall, are FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Until supply is restored, there are alternative therapies including the extended-release version of amphetamine mixed salts available to health care professionals and their patients for amphetamine mixed salts’ approved indications. Patients should work with their health care professionals to determine their best treatment option.

What is FDA doing to address the shortage of Adderall?

  • FDA has posted information on the shortage, including a list of current manufacturers and product strengths that are still available.
  • We will continue to monitor supply and assist manufacturers with anything needed to resolve the shortage and will update our website with new supply information as it becomes available.

FDA’s Drug Shortage Webpage provides additional information about the shortage and is updated regularly. We continue to use all the tools we have available to help keep supply available for patients and will provide public updates regarding the Adderall shortage.


Source: https://www.fda.gov/drugs/drug-safety-and-availability/fda-announces-shortage-adderall

Our ADHD Online corporate office will be closed Thursday, November 24 and Friday, November 25 so our employees can enjoy this special time with their families. 

As always, you can still take our assessment at any time online, whenever and wherever is best for you.

Please note that each clinician sets their own holiday hours and may be processing your requests during this time or they may be out as well.

We will resume normal business hours Monday, November 28. Thank you for your understanding and patience as our staff enjoys time with family to celebrate the Holiday.

Behavioral Therapy

  • Florida
  • Georgia
  • Indiana
  • Michigan
  • Ohio
  • Oregon
  • South Dakota
  • Missouri
  • Texas
  • Tennessee
  • Virginia

Assessments

Assessment services are available in all 50 states.

Assessment and Treatment Plan Development & Implementation**

The patient completes our asynchronous assessment and receives the report from a doctorate-level psychologist within 3-5 days.

The patient schedules an initial appointment with one of our providers to develop a treatment plan through a secure virtual appointment.

The patient schedules subsequent follow-up visits with our providers for ADHD medical treatment or behavioral therapy.

**If available in your state

Assessment and
Treatment Plan Development**

The patient completes our asynchronous assessment and receives the report from a doctorate-level psychologist within 3-5 days.

The patient schedules an initial appointment with one of our providers to develop a treatment plan through a secure virtual appointment. We provide you and your patient with a copy of our full report. You take it from there.

**If available in your state

Assessment

The patient completes our asynchronous assessment and receives the report from a doctorate-level psychologist within 3-5 days.

We provide you and your patient with a copy of our full report. You take it from there.

Assessments available in:

All 50 states

Medical Treatment available in:

Arizona
California
Colorado
Connecticut
Delaware
Florida
Georgia
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky

Maine
Maryland
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Mexico
North Carolina
Ohio

Oregon
Pennsylvania
Rhode Island
South Carolina*
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Washington, DC
Wisconsin

Teletherapy available in:

Georgia 
Michigan 
Missouri 
New Jersey 

Ohio
Pennsylvania
Virginia


*Prescriptions via telemedicine for Schedule II (stimulants) medications are not permitted by state law in South Carolina. Patients can receive prescriptions from our providers for non-stimulant medications. 

south carolina

Prescriptions via telemedicine for Schedule II (stimulants) medications are not permitted by state law in South Carolina. Patients can receive prescriptions from our providers for non-stimulant medications.